Max Hodak’s Science Corp. is preparing to place its first sensor in a human brain

Science Corp., founded by former Neuralog Inc. president Max Hodak, is preparing to implant its first neural sensor device into a human patient. The company has been developing technology designed to interface directly with the brain and spinal cord to monitor and potentially treat neurological conditions through electrical stimulation.

The device aims to deliver gentle electrical stimulation to damaged brain and spinal cord cells to encourage healing and restoration of function. This approach could potentially address multiple neurological conditions, ranging from spinal cord injuries to degenerative diseases, by promoting cellular recovery rather than simply managing symptoms.

The planned human implant represents a significant milestone in the emerging field of neural interface technology. If successful, it could validate a new therapeutic approach for currently difficult-to-treat neurological conditions and establish a foundation for broader clinical applications of brain-computer interface technology in medical treatment.